Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Rea...
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Clinical Trial in Translational Vision Science and Technology (TVST), a prestigious journal by the Association for Research in Vision and Ophthalmology (ARVO). This milestone publication confirms RadiusXR's unwavering commitment to advancing ocular health and heralds a new era in visual field testing. The NOVA Clinical Trial has revealed remarkable findings, including statistical non-inferiority to current clinical standards for sensitivities at individual test locations, glaucoma staging using Medicare definitions, and an exceptionally high correlation of 0.94 in mean deviation. These results underscore the unparalleled accuracy and reliability of RadiusXR's approach to visual field testing for head-mounted virtual reality perimetry. Moreover, unlike other virtual reality perimeters (VRPs), RadiusXR measures vision within the photopic range, aligning with existing visual field platforms' standards. This alignment enables consistent clinical training and facilitates comparison to
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos Announces the Release of its 2023 Sustainability Report [Yahoo! Finance]Yahoo! Finance
- Glaukos Announces the Release of its 2023 Sustainability ReportBusiness Wire
- Here's Why You Should Retain Glaukos (GKOS) Stock for Now [Yahoo! Finance]Yahoo! Finance
- Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally? [Yahoo! Finance]Yahoo! Finance
- Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)? [Yahoo! Finance]Yahoo! Finance
GKOS
Earnings
- 2/21/24 - Miss
GKOS
Sec Filings
- 4/16/24 - Form DEF
- 4/16/24 - Form ARS
- 4/16/24 - Form DEFA14A
- GKOS's page on the SEC website